Laurus Labs Limited

Company Profile

Laurus Labs Limited had its IPO on under the ticker symbol 540222.

The company operates in the sector and industry. Laurus Labs Limited has a staff strength of 0 employees.

Stock update

Shares of Laurus Labs Limited opened at ₹405 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹377.75 - ₹405.45, and closed at ₹384.25.

This is a -5.55% slip from the previous day's closing price.

A total volume of 163,301 shares were traded at the close of the day’s session.

In the last one week, shares of Laurus Labs Limited have slipped by -2.61%.

Laurus Labs Limited's Key Ratios

Laurus Labs Limited has a market cap of ₹0, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months Laurus Labs Limited’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures Laurus Labs Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Laurus Labs Limited’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q0.33333333333333, Laurus Labs Limited’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Laurus Labs Limited’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Laurus Labs Limited’s profitability.

Laurus Labs Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

Laurus Labs Limited stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹76.60 billion

Total Liabilities

₹24.32 billion

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

Laurus Labs Limited ended 2025 with ₹76.60 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹76.60 billion while shareholder equity stood at ₹40.38 billion.

Laurus Labs Limited ended 2025 with ₹0 in deferred long-term liabilities, ₹24.32 billion in other current liabilities, in common stock, ₹33.02 billion in retained earnings and ₹2.46 billion in goodwill. Its cash balance stood at ₹456.70 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹7.61 billion.

Laurus Labs Limited’s total current assets stands at ₹34.62 billion while long-term investments were ₹0 and short-term investments were ₹191.00 million. Its net receivables were ₹15.80 billion compared to accounts payable of ₹7.11 billion and inventory worth ₹16.85 billion.

In 2025, Laurus Labs Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, Laurus Labs Limited paid ₹0 in dividends in 2025.

Other key metrics

Current Trading Price

₹384.25

52-Week High

₹579.5365

52-Week Low

₹278.6462

Analyst Target Price

₹

Laurus Labs Limited stock is currently trading at ₹384.25 per share. It touched a 52-week high of ₹579.5365 and a 52-week low of ₹579.5365. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹377.16 and 200-day moving average was ₹347.25 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.